MIAMI, FL--(Marketwired - December 15, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces strong November 2016 sales.
PharmCo, LLC bested expectations in November, delivering $1.7 million on 18,500 prescriptions filled in the pharmacy. This is a 31% and 23% increase over November 2015, respectively. PharmCo continues to increase revenue by demonstrating the healthcare benefits of the accountable care organization model. PharmCo has developed market awareness in the South Florida healthcare community for its independently developed pharmacy methodology, which has caused numerous unsolicited requests for service from clinics and doctors' office networks.
"Pharmacy services have always played a major role in the health and wellness of patients," stated S. Parikh Mars, CEO. "As the industry moves toward shared risk across the healthcare system, the pharmacy becomes even more vital to lowering the probability of negative health outcomes. Our systems and team of professional technicians and pharmacists have allowed us to offer an unparalleled package of services to our patients as well as the providers and insurance payers who care for them."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.